Mr. Arash Amirpour graduated in 1999 with Master Degree in Natural Sciences from the Technical University of Denmark.
Ever since graduation, his professional work has been dedicated to the pharmaceutical industry. He has obtained experience in the manufacturing area and GMP regulation, while working as an Analytical Chemist in Novo Nordisk and as an QA-Engineer in a subsidiary of Ferring Pharmaceuticals.
In January 2003, he shifted to the area of clinical development and pharmacovigilance by joining International Clinical Quality Assurance department in Nycomed. He left Nycomed as a Senior Auditor to start his position as the Director in CliniQAl Consult Corp, at the end of 2007.
Mr. Amirpour is a certified ISO-9001:2000 Lead Auditor and a very active member of the Pharmaceutical industry. He is multilingual and has experience from several cultural backgrounds. He takes the human relations as an important and at times overseen factor of the absolute success in any pharmaceutical collaboration.
Regardless of the company
size, a streamlined,
flexible, simple and
effective QMS will support
its business as well as
bring added value to the
company.
A small sized company would
obviously have different
needs as well as background
in this area, when compared
to a larger sized company.
Nevertheless, the principles
are the same. A simplified
pyramid that reflects the
company ideology and enables
the individual employee, as
well the company in general,
to identify and perform each
process most efficiently, in
compliance and in the best
interest of the company
business. In case of a
merger or an acquisition, a
lot of the companies’
resources are utilized in
order to harmonize a unified
QMS. This is a cumbersome
process and the success of
these efforts are always in
the focus of the
authorities.
We can provide you with
expert solutions in order to
either establish a system or
optimize the existing one in
order to improve the cost
efficiency.
For many small sized
companies, the shift from
non-clinical research to
clinical development can be
an overwhelming step.
Considering the resources
needed to adapt to a more
regulated area, where the
overall responsibility
always resides with the
sponsor, the company should
consider each step carefully
in order to get it right the
first time and,
consequently, minimize the
cost of development
activities as much as
possible.
Moving forward into
following stages of the
development introduces
several challenges of a more
complex character. Even upon
registration of the drug,
new indications and other
relevant aspects of the drug
can be investigated through
post-marketing
investigations.
Throughout all these phases,
ClniQAl Consult can assist
you bringing the drug to the
market in a fast and
effective manner. We can
help you through the design
phase of your trial
activities as well
performing assessment
activities in order for you
to be assured that all
operations are optimal and
on the track. These
assessments can be performed
as audits of the facilities
and personnel, review of
documents (including
relevant feed-back) etc.
One of the most common and
effective ways of assuring
that operations are
adequately designed and
correctly performed is to
conduct an audit of the
relevant area.
An audit is a systematic and
independent examination of
the activities and documents
in focus in order to
determine whether the
evaluated activities were
conducted, and the data were
recorded, analyzed and
accurately reported
according to all the
applicable requirements.
CliniQAl Consult auditors
are all ISO 9001:2000
certified Lead Auditors, who
with focus on involvement of
management will provide you
with relevant information to
perform the most efficient
risk assessment and identify
the adequate following steps
Pre-audit & Mock
Inspections Anyone operating
within the pharmaceutical
field can become subject to
a regulatory inspection or
an external audit. Not all
personnel or functions are
used to act as an auditee
and it is always a healthy
policy to exercise the
routines that an
inspector/auditor would go
through internally,
beforehand.
CliniQAl Consult has the
expertise to perform a mock
inspection or a pre-audit in
order for the auditee to
become strategically as well
as mentally prepared for the
external visit. We will help
you to identify the system
gaps, discrepancies and
non-compliances before an
external body does. We will
help you, correct and update
your systems, and prepare
plans and next steps, in
order for you to be able to
demonstrate establishment of
your sound path toward
compliance.
When the auditee receives an
audit/inspection report the
relevant management is
responsible that the
necessary follow-up
activities are carried out
in order to insure that the
content of the report is
adequately addressed.
Corrective and Preventive
Actions (CAPA) are expected
to be performed by the
relevant personnel.
It is important to allocate
the needed resources to
assure the adequacy of
follow-up. However, the
balance should be
maintained, if excess
resources should be
eliminated.
CliniQAl Consult has the
knowledge and expertise to
help our clients to stay on
the right track and use its
resources most efficiently.
External requirements
transferred into internal
systems
The world of pharmaceutical
guidelines & regulations
is a complex and, at times,
incompatible environment.
Interpretation of these
requirements can vary a
great deal and, depending on
the framework, the solutions
to comply with these
requirements are diverse.
At CliniQAl Consult we try
to understand your systems’
infrastructure and suggest
solutions that adapt most
successfully to them in
order to support your
business goals.
Depicting the correct safety
profile for a pharmaceutical
drug is being highly
prioritized by the
regulatory bodies around the
world. New legislations are
issued continuously in order
to clarify the requirements
or even add to the existing
ones. Designing an
infrastructure that
facilitates adequate
detection of signals,
performance of qualified
assessments, categorizing
the events/incidents, filing
them in the correct manner
and finally using the
relevant data in order to
detect possible trends
requires resources as well
as continuous
maintenance.
With the risk-based approach
in mind, CliniQAl Consult
will support you in
establishing as well as
maintaining your
pharmacovigilance systems.
We support you, when
outsourcing is considered.
This includes due diligence,
vendor assessment, advice
on/during the kick-off
meeting and ongoing
performance assessment
through audits etc.
The pharmaceutical
development is leaning
heavily towards
collaboration between
different company’s. The
cost of drug development and
the complexity of the world
of pharmaceutical
development, makes most
companies realize the need
of more financial power and
environment know-how, than
they posses internally.
CliniQAl Consult can help
you to identify the most
suitable partner for your
future collaboration.
Validation activities are
often some of the most
costly undertakings a
company or department goes
through. Choosing the right
validation path and
identifying the correct
critical milestones in the
process are crucial for a
successful and compliant
validation outcome.
Equipped with the correct
risk-assessment tools, our
consultants can provide you
guidance or manage your
validation project towards
success.
CliniQAl Consult has Senior
staff with the correct mind
set and adequate experience
to help, when you need to
train your staff or give
presentations to external
guests. Following topics and
forums are examples of the
areas the training or the
presentation can be
given:
- GCP principles and
regulations (e.g. at an
Investigators’ Meeting)
- Validation principles
- Quality Management
(QA/QC)
- Audits &
Inspections
- Drug Safety
Copyright ©2030 CLINIQAL CONSULT All Rights Reserved.